comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 19:26:43 - browse：5

Richard Neal(D-MA), Rep. Frank Pallone (D-NJ),Rep. John Yarmuth (D-KY), Rep. Bobby Scott (D-VA) and House Minority Leader Nancy Pelosi (D-CA) attend the weekly press conference in the Capitol building on July 20, 2017 in Washington, DC. They spoke to the media about the efforts to reform the health care bill. -- health policy coverage from STAT — Reps. Richard Neal (D-Mass.), Rep. Frank Pallone (D-N.J.), and Rep. John Yarmuth (D-Ky.) Joe Raedle/Getty Images

WASHINGTON — It’s drug pricing déjà vu: Just as they did in 2019, House Democrats are pushing a bill that would allow Medicare to negotiate dozens of drug prices a year, offer those prices to all insurers, and crack down on price hikes.

Unlike then, Democrats have a starting place: the new bill represents an expansion of the major drug pricing legislation the party passed last year. But the first round of drug price negotiations hasn’t even started yet, and the law is under attack from the pharmaceutical industry in court.

The Democratic leaders of three key House committees put forth the proposal Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The FDA weighs the risks of candy

hotspot

knowledge

WSS

Readout Newsletter: What happened with Sarepta's Duchenne data

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Why don't Americans have at

Abbott's new heart device gets FDA advisory panel nod

Senate panel to vote on hospitals, PBMs, prisoner care

Readout Newsletter: What happened with Sarepta's Duchenne data

leisure time

comprehensive

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

First Opinion Podcast: How to protect health care in times of war

How to save PrEP access — and even expand it

Hospitals warn Medicare's drug payment fix is ‘unlawful’

State Dept. review finds Biden bears some blame for Afghanistan failures

Doctors on social media are being harassed and cyberbullied

23andMe had bad news about my health. I wish a person had delivered it

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Peter Hotez and the public health issue of online harassment

Latigo launches with $135 million for Vertex

Wikipedia

Testing for cancer recurrence creates a new limbo for patients

Resistance to opioid

Biden's order seeks to regulate AI risk without stifling innovation

Latigo launches with $135 million for Vertex

Readout Newsletter: XBI biotech index, Akero Therapeutics

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

hotspot

hotspot

knowledge

explore